Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PCI Biotech Holding ASA ( (DE:4QG) ) has provided an announcement.
Euronext Oslo Børs has placed PCI Biotech Holding ASA in its Recovery Box as of 30 January 2026, a special trading compartment used when an issuer faces circumstances that make share pricing particularly uncertain; securities remain there until those issues are resolved. The update underlines heightened risk around PCI Biotech’s share valuation and signals to investors that trading is occurring under exceptional conditions, while also clarifying that other issuers are currently subject to similar measures either in the Recovery Box or the Penalty Bench, the latter applying to companies that have failed to comply with exchange rules and remain there until violations are corrected.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norway-listed biotechnology company whose shares trade on Euronext Oslo Børs, exposing it to the exchange’s specific trading compartments and regulatory regimes, including measures applied when pricing certainty or rule compliance is in question.
YTD Price Performance: -36.18%
Average Trading Volume: 152,492
Current Market Cap: NOK5.88M
Learn more about 4QG stock on TipRanks’ Stock Analysis page.